The VNGOC together with NYNGOC and the UNODC Civil Society Unit is organizing an online side event in the margins of the 2023 ECOSOC Partnership Forum on 31 January 2023 at 8.30 AM. The event is titled: The central role of civil society in drug policies, COVID-19 and achieving the 2030 Agenda

Breve descripción:

La Secretaría Ejecutiva de la Comisión Interamericana para el Control del Abuso de Drogas (ES-CICAD) está buscando expresiones de interés de expertos en el campo de las alternativas al encarcelamiento y la integración social para ser capacitados como Instructores Maestros para la entrega del currículo de Gestión de Casos a nivel internacional. Una vez que se complete con éxito la Capacitación de Capacitadores, estos Capacitadores Maestros se incluirán en la lista de capacitadores de Case Care Management y se puede contactar para impartir la capacitación cuando esté...

Dear friends and colleagues, 

The Commission on Narcotic Drugs is starting very soon! In fact, tomorrow, Monday, 14 March 2022. 

Once again, all sessions, as well as the side events, are to be held online due to the pandemic. The good thing about that means that, you can still follow the plenaries and the side events! That’s why we thought that you might appreciate having all the links in one place.

GENERAL LINKS TO FOLLOW CND

• Link to 65th session with general information on organizational arrangements: https://www.unodc.org/unodc/en/commissions/CND/session/65_Session_2022/65CND...

Hybrid effectiveness-implementation trial designs have become increasingly prevalent in implementation research. As hybrid designs enter their second decade of widespread use, the Frontiers in Health Services’ Implementation Science section launches a Research Topic to fuel the field’s discourse on the past, present, and future of hybrid designs in knowledge translation. Submissions are welcome of both Original and/or Brief Research, Review, Methods, and Perspective articles. The call addresses critical assessments of hybrid designs, innovative use of hybrid designs in current trials, and...